Vax-Immune, LLC is focused on preventing and treating life threatening infections in pregnant women and babies through rapid diagnosis.LabReady(TM), our initial platform device, is a first in the world point of care, hand-held, portable, disposable, sampler and incubator. It is easily used by patients and practitioners anytime, anywhere. It strips out the inefficient time lapse between sample collection and laboratory processing, leading to faster results with better outcomes, and decreased costs.
Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology.Amarantus is active in exploring a number of strategic options for Amarantus Diagnostics, including a potential spin off, to derive the full value of its premier neurodiagnostics business.
SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 80,000 employees, SGS operates a network of over 1,650 offices and laboratories around the world. We are constantly looking beyond customers’ and society’s expectations in order to deliver market leading services wherever they are needed. As the leader in providing specialized business solutions that improve quality, safety and productivity and reduce risk, we help customers navigate an increasingly regulated world.…
ZS Genetics, Inc. engages in the research, development, and commercialization of a single-molecule technology for DNA sequencing. The company develops electron microscopy-based DNA sequencing technology, which is used to read DNS sequences directly from digital images of DNA itself. Its technology is used in various applications in genomics research and diagnostic markets. The company was founded in 2003 and is based in Wakefield, Massachusetts.
Structured BioEquity's (SBE's) innovative financial product enables sustainability for clinical-stage biotechnology companies by offering an insurance policy on the high attrition rate of Phase II therapeutic drug candidates. SBE's STanDaRD (Sustainability for the FuTure of DRug Development) product transfers technical risk to the capital markets at the time in a drug candidate's lifecycle when the greatest amount of uncertainty is traded for the greatest amount of enterprise value. SBE is a technology-enabled company applying a proven risk-transfer model in the $15.6B market of "alternative…
Applied Minerals is the leading producer of halloysite clay and advanced natural iron oxide solutions from its wholly-owned Dragon Mine property in Utah. Halloysite is aluminosilicate clay that forms naturally occurring nanotubes. In addition to serving the traditional halloysite markets for use in technical ceramics and catalytic applications, the Company has developed niche applications that benefit from the tubular morphology of its halloysite. These applications include carriers of active ingredients in paints,coatings and building materials, environmental remediation,agricultural…
Auritec Pharmaceuticals, Inc. is a research and development (R&D) company, specializing in innovative, extended release drug delivery systems. Auritec was founded by Thomas J. Smith, MD. Dr. Smith was previously Medical Director and Chairman at Control Delivery Systems, Inc. (CDS), where he was the co-founder and PI on key patents. CDS, now Psivida Inc. (NASDQ - PSDV), is a successful device company specializing in ophthalmic extended release therapies. Dr. Smith is joined on Auritec's management team by Gary Ransom, a seasoned international business executive, who focuses on strategy,…
Marsala Biotech Inc. is an Oncology company developing new treatments for cancer. The Company's lead technology E10A, is being evaluated in head and neck cancer patients. Currently there are only 2 FDA approved drugs which have significant drawbacks. Phase III clinical trials of E10A are planned for 2013 in China and North America. In addition to a huge commercial potential, E10A would help address this significant unmet medical need.Marsala's lead product E10A has established potential to treat Head and Neck Cancer, which has a market potential of 3.2 billion USD. E10A also has synergistic…
Sequenom, Inc.Sequenom, Inc. (NASDAQ: SQNM) designs, develops, manufactures and markets innovative technology, instrumentation and tests that target and serve discovery and clinical research, and clinical molecular diagnostics markets. Applications include translational research, oncology, agricultural genomics and in vitro diagnostics for prenatal and retinal disorders.Technologies employed include mass spectrometry and second generation DNA sequencing. The company's proprietary MassARRAY system is a high-performance mass spectrometry based DNA analysis platform that efficiently and…
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives depend on our work.Our first commercial product is Soliris® (eculizumab), the world's first and only approved terminal complement inhibitor. Today, Soliris is approved in…
The biggest unmet medical need is to provide safe and efficacious drugs to the patient. However, the pharmaceutical industry is currently facing a litany of challenges, including but not limited to: 1) lead identification; 2) lead optimization & prioritization; 3) predicting side effects and toxicity; 4) meeting efficacy requirements; 5) maximizing patent life on the market; and 6) product rescue/repositioning. As a result, R&D success rates are falling, and R&D spending is not contributing to increased sales. According to research by Jack Scannell published in Nature, “...the number of new…
Cubist Pharmaceuticalsis a bio-pharmaceutical company focused on the research, commercialization and creation of pharmaceutical products that address unmet medical needs in the acute care environment.
Vystar Corporation holds four domestic US patents and multiple global patents to remove the antigenic proteins from natural rubber latex. Vytex is the brand name and is used in adhesives, balloons, condoms, gloves, foam, etc. The most prevalent is our recent foray into the domestic mattress, toppers and pillow markets.
About LubrizolLubrizol may not be a household name, but chances are good that you'll find Lubrizol products throughout your home…your workplace…anywhere your day takes you. As a company, we strive to be an essential ingredient in our customer's success through collaboration, applied science and demonstrated value. By formulating complex chemicals at the molecular level, Lubrizol engineers and chemists develop additives, ingredients and compounds that amplify the quality and performance of other products while reducing their environmental impact. And those products cover a wide range of…
QUADRAS is a global provider of unique, enterprise-class Data Collection and Professional Service solutions, with a specialization in mobile data capture and RFID technologies. Our business solutions are focused on optimizing operations, reducing expenses, and improving business processes, and they have successfully been applied across a wide range of industries.As recognized leaders in the Data Collection, RFID, and EAM/IT Consulting fields, we stand behind our know-how, our recommendations, and our implementations - we will execute what we promise and help you attain your key performance…
At Camargo Pharmaceutical Services, we are strategic thinkers and doers. Camargo is your full-service drug development partner specializing in the 505(b)(2) process — a holistic approach for developing products that offer differentiated benefits. Before development even begins, we help verify profit potential by working with your team to develop a comprehensive program and timeline complete with critical milestones and cost objectives. We manage every facet of the plan throughout your development continuum, from feasibility assessments, formulation and testing the drug product, to…
U-M Tech Transfer is the University organization responsible for the transfer of University technology to the marketplace.Mission:To effectively transfer University technologies to the market so as to generate benefits for the University, the community and the general public.
Neurotez, Inc. is a private corporation whose primary goal is to develop a Leptin product as a novel hormone replacement therapy for Alzheimer's disease (AD) and/or as a preventative for those who are at risk.Leptin, a naturally occurring human hormone associated with various metabolic effects, has a large number of receptors in memory centers of the brain. This protein is often present at decreased levels in patients suffering from Alzheimer's disease, and cognitive deterioration in AD patients correlates strongly with a decline in circulating Leptin levels. The administration of Leptin…
MEDITEX is an invention and business development incubator dedicated to new medical technologies and healthcare services. We invent, design, develop, and commercialize innovative solutions for medical and healthcare industry. The main focus of MEDITEX is on early detection and treatment of cardiovascular disease as well as home or mobile-based preventive healthcare solutions. Using a business incubator portfolio approach, our experienced management team of medical doctors, engineers, lawyers, and business experts in collaboration with other entrepreneurs and investors transform early stage…
